Literature DB >> 16343009

Reducing nonspecific adhesion on cross-linked hydrogel platforms for real-time immunoassay in serum.

Shawn D Carrigan1, Maryam Tabrizian.   

Abstract

Biointerfaces that limit nonspecific adhesion of serum proteins have been developed by relying solely on cross-linked hydrogels. In addition to being characterized for adhesion of serum proteins, immunoassay sensitivity was also investigated through a sandwich assay for rhIL-1ra. Among the compositions developed, the optimal surface is comprised of pre-cross-linked carboxymethylcellulose (CMC) and polyethyleneimine (PEI) overlaid on a cross-linked layer of poly(ethylene glycol) (PEG) and PEI and employs an anti-IgG Fc specific ligand for oriented antibody immobilization; viscoelastic modeling provides a thickness estimate of 5 nm for the hydrogel alone, rising to 33 nm after the deposition of antibodies. Alternate compositions employing a Protein A ligand and PEG at the exposed surface of the biointerface were disfavored due to an 8-fold increase in serum adhesion and retarded immobilization kinetics, respectively. Through the rapid deposition provided by hydrogels, construction of the entire biointerface, including receptor immobilization, can be completed in 1 h. Based on QCM-D measurements, estimated nonspecific serum adsorption using these compositions is as low as 1.1 ng/mm2. The immunoassay as developed requires 10 min, providing a detection limit of 500 ng/mL rhIL-1ra in 25% human serum using only 5 microg of the secondary antibody.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343009     DOI: 10.1021/la052046h

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  1 in total

1.  Lipoic acid glyco-conjugates, a new class of agents for controlling nonspecific adsorption of blood serum at biointerfaces for biosensor and biomedical applications.

Authors:  Yanyan Wang; Kheireddine El-Boubbou; Hovig Kouyoumdjian; Bin Sun; Xuefei Huang; Xiangqun Zeng
Journal:  Langmuir       Date:  2010-03-16       Impact factor: 3.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.